Beyond Kaftrio: mechanistic insights to maximize N1303K-CFTR rescue

Pranke, I.; Capurro, V.; Chevalier, B.; Pesce, E.; Tomati, V.; Pastorino, C.; Hatton, A.; Urien, S.; Lena, M.; Dreano, E.; Bocciardi, R.; Zara, F.; Pantano, S.; Terlizzi, V.; Lucanto, C.; Costa, S.; Claut, L.; Dacco, V.; Poli, P.; Maschio, M.; Fabrizzi, B.; Caporelli, N.; Cipolli, M.; Volpi, S.; Jung, V.; Roger, K.; Chedevergne, F.; Cosson, L.; Macey, J.; LeBihan, J.; Weiss, L.; Grenet, D.; LeClainche Viala, L.; Douvry, B.; Ravoninjatovo, B.; Audousset, C.; Tatopoulos, A.; Richaud Thiriez, B.; Baravalle, M.; Thouvenin, G.; Labbe, G.; Mittaine, M.; Reix, P.; Durieu, I.; Mankikian, J.; Bui, S.

doi:10.1101/2024.02.29.582514

Home/Archive/bioRxiv

bioRxiv · 10.1101/2024.02.29.582514

Beyond Kaftrio: mechanistic insights to maximize N1303K-CFTR rescue

View original source ↗Export metadata ↓

Abstract

IntroductionN1303K is the fourth most frequent Cystic Fibrosis (CF) causing mutation. People with CF (pwCF) clinical status can be improved by Elexacaftor(ELX)/Tezacaftor(TEZ)/Ivacaftor (ETI) combotherapy. We investigated the mechanism underlying N1303K-CFTR rescue. MethodsN1303K-CFTR expression and maturation was evaluated by Western Blot in cell lines and Human Nasal Epithelial Primary Cells (HNECs). Cell surface expression was studied by nanoluciferase complementation assay and TurboID proximity labeling. Functional rescue was tested in vitro by YFP-Based Assay and Short Circuit Current. ResultsCorrection by ELX/TEZ increases N1303K-CFTR amounts, but not its maturation in CFTR-expressing HEK and 16HBEge cell lines and in HNECs. In control conditions, N1303K-CFTR is more distributed at the cell surface and significantly more surface partners are identified in the N1303K-CFTR interactome as compared to F508del-CFTR in HEK cells. ELX/TEZ induces a global stabilization of N1303K-CFTR without favoring its plasma membrane relocation in contrast to F508del-CFTR which is redistributed to the membrane. ETI increases N1303K-CFTR activity in HNECs and can be increased by API co-potentiation with a predicted increase in Forced Expiratory Volume in 1 second (ppFEV1) by respectively 13(2)% and 18%(3). This is consistent with a gain in ppFEV1 reported in pwCF carrying the N1303K mutation and additional improvement by API in a patient. ConclusionThese results support the expansion of ETI approval to N1303K mutation but highlight different mechanisms of action than for F508del.

Explore related subjects

physiology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Pranke, I., Capurro, V., Chevalier, B., Pesce, E., Tomati, V., Pastorino, C., Hatton, A., Urien, S., Lena, M., Dreano, E., Bocciardi, R., Zara, F., Pantano, S., Terlizzi, V., Lucanto, C., Costa, S., Claut, L., Dacco, V., Poli, P., Maschio, M., Fabrizzi, B., Caporelli, N., Cipolli, M., Volpi, S., Jung, V., Roger, K., Chedevergne, F., Cosson, L., Macey, J., LeBihan, J., Weiss, L., Grenet, D., LeClainche Viala, L., Douvry, B., Ravoninjatovo, B., Audousset, C., Tatopoulos, A., Richaud Thiriez, B., Baravalle, M., Thouvenin, G., Labbe, G., Mittaine, M., Reix, P., Durieu, I., Mankikian, J., Bui, S.. 2024-03-03. Beyond Kaftrio: mechanistic insights to maximize N1303K-CFTR rescue. https://doi.org/10.1101/2024.02.29.582514

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Hypothalamic Farnesoid X Receptor deficiency alters energy balance by modulating hepatic glucose production and adipose tissue metabolism through central insulin signaling.

Objectives: The bile acid nuclear receptor Farnesoid X Receptor (FXR, NR1H4) is a major regulator of metabolism and energy homeostasis in peripheral organs. It modulates bile acid, glucose, and lipid metabolism, as well as fat mass and body weight. However, FXR is also expressed in the brain, particularly in the hypothalamus, a key center for the regulation of energy homeostasis. Although one study has demonstrated a role for brain FXR activation in energy balance, its specific hypothalamic role is still unknown. Here, we examined the role of FXR in the mediobasal hypothalamus in the regulation of energy balance. Methods: We used a genetic approach combined with metabolic phenotyping to determine the effect of FXR invalidation in the mediobasal hypothalamus on metabolic parameters involved in the central regulation of energy homeostasis. Results: Our results demonstrate that hypothalamic FXR deficiency induces a positive energy balance, resulting in a reduction in energy expenditure due to alterations in glucose metabolism accompanied by structural changes in white adipose tissues. Conclusion: This study uncovers a previously unrecognized role for hypothalamic FXR in the central homeostatic control of energy balance, providing new insights into its contribution to peripheral glucose metabolism and adipose tissue structural remodeling.

physiology↗

bioRxiv2026

Rad and Phospholamban are Key Drivers of the Ventricular Adrenergic Response and Stress-Induced Arrhythmia

The adrenergic response is a fundamental mechanism that regulates heart rate (chronotropy), cardiac contractility (inotropy) and relaxation (lusitropy). Adrenergic stress is also a recognized trigger of arrhythmia in disease. Yet, our understanding of the underlying molecular basis remains incomplete. Protein kinase A (PKA) and the calcium/calmodulin-dependent kinase II (CaMKII) phosphorylate multiple targets proposed to participate in the adrenergic response, including the GTP-binding protein Rad, phospholamban (PLB) and ryanodine receptor 2 (RyR2). Here we demonstrate that phosphorylation of both Rad and PLB is necessary for inotropy and lusitropy. We show that changes in cardiac contractility and relaxation are primarily dependent on intracellular calcium handling. Finally, we report that Rad and PLB control stress-induced arrhythmogenesis, despite the phosphorylation of other pro-arrhythmic targets. We have identified the essential molecular components of the adrenergic response, resolving a long-standing debate in cardiac excitation-contraction coupling and refining current models of sympathetic regulation in health and disease.

physiology↗

bioRxiv2026

Light-cycle time-restricted feeding remodels a hidden layer of the cardiac transcriptome through sex-specific transcript switching

Light-cycle time-restricted feeding disrupts daily cardiovascular and thermoregulatory rhythms, but the molecular effects of light-cycle time-restricted feeding on the heart have been measured only at the level of total gene expression. We used Oxford Nanopore long-read RNA sequencing to resolve the full-length ventricular transcriptome from male and female mice under ad libitum feeding or light-cycle time-restricted feeding across the 24-hour cycle. Greater than 20% of cardiac transcripts represent unannotated variants of known genes absent from the current GENCODE reference annotation. Light-cycle time-restricted feeding reorganizes transcript usage across hundreds of genes, including genes encoding splicing regulators, largely without changing total gene expression. The genes affected are sex-specific, with fewer than 2% of changes shared at the gene, transcript, and transcript-usage levels. We show that transcript-level regulation is a previously underrecognized component of the cardiac response to altered feeding behavior, undetected by conventional short-read approaches.

physiology↗